Ramy Farid has sold SDGR and made no open-market buys since Aug 2020

Ramy Farid, Ph.D. is the President and CEO of Schrödinger, Inc. (SDGR), a position he has held since January 2002, along with prior roles including Board Director, Senior Vice President, and Vice President of Scientific Development and Product Management at the company.(

Farid earned a Ph.D. in Chemistry from Caltech (1986-1991) and a B.S. in Chemistry from the University of Rochester, followed by postdoctoral work as an NIH Fellow at the University of Pennsylvania School of Medicine and serving as an Assistant Professor of Chemistry at Rutgers University.( He currently serves on the boards of Vir Biotechnology, Inc., Structure Therapeutics, and Ajax Therapeutics, with previous board roles at Oak Hill Bio and Nimbus Therapeutics.( As CEO, Farid advocates for integrating physics-based calculations with AI in drug discovery.(

Written by Perplexity from public sources.